Chinese Pharmaceutical Affairs 2011 Issue 11 The Problems on the Declared Date for Registration of Preparations in Medical Institutions and Corresponding Suggestions

The Problems on the Declared Date for Registration of Preparations in Medical Institutions and Corresponding Suggestions
Jia Na;Wang Li;Zhang Keliang;Hu Chunli;Shen Wenjuan;Chen Fujun

..............page:1100-1103

Role Characteristics and Clinical Assessment of ADR about Andrographolide and Its Derivatives
Cheng Guoyin;Li Hongju

..............page:1132-1135

Use Analysis of Antihypertensive Drug in Our Hospital from 2006 to 2010
Xu Chengheng;Liu Meisheng

..............page:1158-1160,封3

Advances in Research on Mono-carbonyl Analogues of Curcumin
Sui Sibo;Liu Yifan;Geng Wei;ZhangMin;Li Xiaokun;Yang Ping

..............page:1126-1129

Determination of Naringin in Tongxuanlifei Tablets by HPLC
Li Xiaojun

..............page:1121-1122,1125

The Legal Status of Drug Inserts and Validity of Usage beyond Drug Inserts
Li Haona;Huang Hu;Ma Chengyan;Zhang Zhengguang

..............page:1107-1108

Analysis of 31 Cases ADRs Caused by Aztreonam
Zhang Fengqin;Zheng Dongsheng;Jin Yinghua;Yuan Dongmin

..............page:1153-1154,封3

Antibacterials Usage and Analysis of Bacterial Resistance in Our Hospital
Wei Ling

..............page:1155-1157

Establishment of Management Specification for National Pharmaceutical Reference Standards Library
Su Lihong;Ma Lingyun;Yao Lingwen;Ma Shuangcheng

..............page:1094-1096

Investigation on Cognition and Implementation of the Preparations of Pharmaceutical Manufacturers in Henan Province to the New Version of GMP
Song Lili;Gao Jie;Zhang Zhichao

..............page:1136-1139

Thinking on Construction of Quality Management Standards in Emerging Pharmaceutical Companies
Zhu Yanling

..............page:1097-1099

Discussion on the Issue of Operations beyond Licensed Scope of Drugs and the Solution
Yu Peiming;Yue Shumei;Song Lili

..............page:1072-1074

Discussion on the Government Behavior in the Development for the Pharmaceutical Industry Clusters
Chen Yuwen;Meng Lingquan;Huang Zhengzheng

..............page:1068-1071

Determination of Luteolin in Folium Callicarpae Macrophyllae by RP-HPLC
Wei Zhijiang;Qin Zhongyu;Qin Lili;Wei Jianqiao;Meng Lulu

..............page:1115-1116,1120

Jurisprudence Thinking on Rights and Interests Protection of Chinese Human Subjects of Drug Clinical Research
Shao Rong;Zhang Yue;Wei Wei

..............page:1065-1067,1093

Introduction of Accreditation Program of the College of American Pathologists
Miao Yufa;Geng Xingchao;Liu Fang;Pan Dongsheng;Wang Xiuwen;Li Bo

..............page:1143-1147

Sustainable Use Situation and Proposal of Traditional Chinese Medicine Resources
Zhang Nanping;Wei Feng;Xiao Xinyue;Lin Ruichao

..............page:1079-1082

xin xi dong tai

..............page:1082,1085,1106,封2

Impact of FDA Foreign cGMP Compliance Inspection on Chinese Pharmaceutical Manufactures
Han Wentao;Zhang Tiejun;Wang Yanwen

..............page:1140-1142,1147

Problems of Vaccine Management Enterprise and Their Countermeasures
Wei Hua;Huang Chuanhua

..............page:1083-1085

Practice and Experience of Prescription Evaluation
Feng Baoming

..............page:1109-1112

LC-MS/MS Determination of a Natural Novel Tyrosinase Inhibitor UP302 in Rat Skin Homogenate and ItsApplication to Evaluate Skin Absorption Amount and Skin Metabolic Stability
Yu Min;Zhang Shuangqing;Zhu Ling;Wen Nie;Li Zuogang

..............page:1089-1093

Study on the Information Sharing Technology of Internet Drug Market Entity
Dun Bin;Lu Ying;Hong Xiaoshun;Lu Ming

..............page:1059-1062

Some Considerations about Bioassay Tests in Traditional Chinese Medicine
Tan Dejiang;Lu Jing

..............page:1086-1088

Literature Review on 17 ADR Cases Induced by Linezolid
Fu Xiaoqin;Yu Xiongjie;Liu Shengyou

..............page:1130-1131

A Comparative Analysis Between the New Version of Measures for the Reporting and Monitoring of Adverse Drug Reactions and the Original One
Hou Yongfang;Wang Dan;Tian Chunhua;Wang Ling;Du Xiaoxi

..............page:1075-1078,1088

Analysis on ADR of Quinolones Antibiotics Drug in Bengbu City from 2009 to 2010
Xing Rong;Xie Dongmei;Xu Jian;Shi Peilan;Guo Daohua;Zhang Shuqiang

..............page:1150-1152

Studies on Determination of Linarin and Luteolin in Flos Chrysanthemi Indici by HPLC
Li Zhengguo;Wang Hong;Wang Yurong

..............page:1117-1120

Discussion on Definition of the Sample Size in the Drug Sampling
Geng Dongsheng

..............page:1104-1106

Experience of Clinical Pharmacy in Our Hospital
Lu Wei;Jiang Peng;Zhang Shaohua

..............page:1113-1114

Implementation of the “6S” Management Philosophy to Improve the Level of Drug Testing Laboratory On-site Management
Yan Xiaohang

..............page:1063-1064

Comparison Study on Effectiveness and Safety of 5 Drugs in the Treatment of General Anxiety Disorders
Yan Guiliang;Duan Jianrong

..............page:1148-1149,1152

Simultaneous Analysis of Eleven Fatty Acids in Saw Palmetto Capsules by GC
Xu Jia;Sun Lei;Jin Hongyu

..............page:1123-1125